Form 4 Filing for Alpha Tau Medical Ltd.

2026-07-01SEC Filing 4 (0001213900-26-074011)

This filing details a transaction by Raphi Levy, the Chief Financial Officer of Alpha Tau Medical Ltd. On June 30, 2026, Levy disposed of 20,000 ordinary shares at a price of $12.0022 per share. Following this transaction, Levy directly owns 90,180 ordinary shares of the company. The transaction code "S" indicates a sale, and "D" signifies a direct ownership disposition.